Feedback (FDBK)

Sector:

Health Care

Index:

FTSE AIM All-Share

130.00p
   
  • Change Today:
    -10.00p
  • 52 Week High: 157.50
  • 52 Week Low: 58.00
  • Currency: UK Pounds
  • Shares Issued: 13.33m
  • Volume: 22,878
  • Market Cap: £17.34m
  • RiskGrade: 267

Feedback awarded two year-long NHS contracts

By Josh White

Date: Tuesday 12 Apr 2022

LONDON (ShareCast) - (Sharecast News) - Clinical communications specialist Feedback has been awarded two 12-month contracts to provide its flagship product 'Bleepa' across two NHS trusts, it announced on Friday, for a total value of £0.2m.
The AIM-traded firm said the first contract followed a successful pilot and co-development on the platform over the last two years, representing the first full-cycle realisation of its pilot-to-contract business model.

It said the second contract was a renewal, following the success of an initial one-year contract, at a higher value than the initial contract.

"We are delighted to see the value of Bleepa as a core clinical system recognised through the award of two customer contracts," said chief executive officer Tom Oakley.

"Over the last year we have significantly grown the number of Bleepa users and it is good to see this growth recognised in the uplift in contract value achieved.

"These contracts are early evidence of the success of our 2019 strategic shift."

At 1224 BST, shares in Feedback were up 7.02% at 0.72p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Feedback Market Data

Currency UK Pounds
Share Price 130.00p
Change Today -10.00p
% Change -7.14 %
52 Week High 157.50
52 Week Low 58.00
Volume 22,878
Shares Issued 13.33m
Market Cap £17.34m
RiskGrade 267

Feedback Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.29% below the market average46.29% below the market average46.29% below the market average46.29% below the market average46.29% below the market average
6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average
Price Trend
61.60% above the market average61.60% above the market average61.60% above the market average61.60% above the market average61.60% above the market average
72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average
Income Not Available
Growth
48.94% above the market average48.94% above the market average48.94% above the market average48.94% above the market average48.94% above the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Feedback Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
13:58 1,244 @ 134.00p
13:57 914 @ 129.87p
11:55 7,500 @ 136.00p
12:42 1,500 @ 125.50p
12:34 500 @ 132.00p

Feedback Key Personnel

CEO Tom Oakley
CFO Anesh Patel

Top of Page